Arena shares rise on favorable diet pill review
WASHINGTON — Shares of Arena Pharmaceuticals Inc. continued to rise Wednesday, a day after federal health regulators issued a surprisingly favorable assessment of the company's previously rejected diet pill. The Food and Drug Administration denied …
See all stories on this topic »